CIK: 0001540358 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $312,909 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,748,523 | $101,118 | 32.3% | $24.03 | +59.9% | COM | 76155X100 |
| OMDA | OMADA HEALTH INC | 4,614,574 | $84,447 | 27.0% | $17.31 | 0.0% | COM | 68170A108 |
| XYZ | BLOCK INC | 1,016,697 | $69,064 | 22.1% | $56.54 | +2.9% | CL A | 852234103 |
| MAZE | MAZE THERAPEUTICS INC | 1,702,225 | $20,886 | 6.7% | $12.04 | -13.6% | COM | 578784100 |
| BIOA | BIOAGE LABS INC | 3,233,170 | $13,353 | 4.3% | $19.85 | -79.7% | COM | 09077V100 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 17,653,917 | $12,797 | 4.1% | $2.86 | -73.7% | COM | 63909J108 |
| ERAS | ERASCA INC | 2,862,500 | $3,635 | 1.2% | $2.11 | -36.6% | COM | 29479A108 |
| OPEN | OPENDOOR TECHNOLOGIES INC | 6,200,821 | $3,305 | 1.1% | $2.89 | -74.1% | COM | 683712103 |
| CAMP | CAMP4 THERAPEUTICS CORP | 2,125,339 | $3,082 | 1.0% | $8.22 | -75.8% | COM | 13463J101 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 108,568 | $1,221 | 0.4% | $10.02 | -22.7% | CL A NEW | 37611X209 |